UroVaxom

UroVaxom
Vaccine description
TargetEscherichia coli
Vaccine typeInactivated
Clinical data
Trade namesUroVaxom
Other namesOM-89; OM-8980
Routes of
administration
Oral (tablet)

UroVaxom (developmental code names OM-89, OM-8980) is a vaccine against urinary tract infections (UTIs). It is an extract of 18 strains of killed Escherichia coli administered as an oral tablet once daily for 3 months. The vaccine is marketed for use in the prevention of recurrent UTIs in some European countries. It was also being studied for treatment of prostatitis but was discontinued. UroVaxom was initially developed in the 1980s.

See also